The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers

Published:2015-05-28 Issue:4 Volume:80 Page:678-686
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Schievink Bauke¹^ORCID,de Zeeuw Dick¹,Parving Hans-Henrik²³,Rossing Peter⁴,Lambers Heerspink Hiddo Jan¹

Affiliation:

1. Department of Clinical Pharmacy and Pharmacology, University of Groningen; University Medical Center Groningen; Groningen the Netherlands

2. Department of Medical Endocrinology, Rigshospitalet; University of Copenhagen; Copenhagen

3. Department of Medical Endocrinology, Rigshospitalet, HEALTH; Aarhus University; Aarhus Denmark

4. Steno Diabetes Center, Gentofte, NNF Center for Basic Metabolic Research University of Copenhagen, Copenhagen, HEALTH; Aarhus University; Aarhus

Funder

Top Institute Pharma

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12655/fullpdf

Reference34 articles.

1. Antihypertensive therapy in diabetes: The legacy effect and RAAS blockade;Volpe;Curr Hypertens Rep,2011

2. The evolving story of the RAAS in hypertension, diabetes and CV disease ? moving from macrovascular to microvascular targets;Steckelings;Fundam Clin Pharmacol,2009

3. The kidney in type II diabetes therapy;Heerspink;Rev Diabet Stud,2011

4. An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: A post-hoc analysis of the RENAAL and IDNT trials;Smink;J Hypertens,2012

5. Increased serum potassium affects renal outcomes: A post hoc analysis of the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) trial;Miao;Diabetologia,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach;Clinical Diabetes;2023-06-02

2. Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [ ¹¹ C ]Telmisartan;Clinical Pharmacology & Therapeutics;2022-09-30

3. Up-Date on Diabetic Nephropathy;Life;2022-08-08

4. Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease;International Journal of Molecular Sciences;2022-05-20

5. Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers;Frontiers in Pharmacology;2022-04-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3